Edition:
United Kingdom

Adverum Biotechnologies Inc (ADVM.OQ)

ADVM.OQ on NASDAQ Stock Exchange Global Market

5.98USD
18 Apr 2019
Change (% chg)

$0.33 (+5.84%)
Prev Close
$5.65
Open
$5.60
Day's High
$6.17
Day's Low
$5.60
Volume
115,333
Avg. Vol
92,588
52-wk High
$7.70
52-wk Low
$2.62

About

Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases. Adverum has a robust pipeline that includes product candidates designed to treat rare diseases alpha-1 antitrypsin (A1AT) deficiency and hereditary angioedema (HAE) as well as wet age-related... (more)

Overall

Beta: --
Market Cap(Mil.): $153.67
Shares Outstanding(Mil.): 43.29
Dividend: --
Yield (%): --

Financials

  ADVM.OQ Industry Sector
P/E (TTM): -- 69.30 32.55
EPS (TTM): -1.53 -- --
ROI: -28.12 8.91 13.83
ROE: -29.20 10.06 15.25

Earnings vs. Estimates